|
1
|
Vaccine-induced myeloid cell population dampens protective immunity to SIV.
|
J Clin Invest
|
2014
|
1.64
|
|
2
|
Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.
|
Neoplasia
|
2007
|
1.07
|
|
3
|
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells.
|
J Exp Med
|
2013
|
1.03
|
|
4
|
Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors.
|
Clin Cancer Res
|
2010
|
0.96
|
|
5
|
Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
|
Cancer Res
|
2002
|
0.92
|
|
6
|
Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity.
|
Vaccine
|
2007
|
0.90
|
|
7
|
TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.
|
Vaccine
|
2011
|
0.85
|
|
8
|
The calf model of immunity for development of a vaccine against tuberculosis.
|
Vet Immunol Immunopathol
|
2008
|
0.81
|
|
9
|
Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
|
Cancer Res
|
2004
|
0.81
|
|
10
|
In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.
|
Methods Mol Med
|
2004
|
0.78
|
|
11
|
Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
|
J Med Chem
|
2004
|
0.78
|
|
12
|
Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
|
J Med Chem
|
2007
|
0.77
|
|
13
|
Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum.
|
J Acquir Immune Defic Syndr
|
2016
|
0.77
|